These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1535141)

  • 21. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.
    Teixeira RA; Borba EF; Pedrosa A; Nishioka S; Viana VS; Ramires JA; Kalil-Filho R; Bonfá E; Martinelli Filho M
    Europace; 2014 Jun; 16(6):887-92. PubMed ID: 24050965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
    Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G
    Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine neuromyopathy, a reversible granulovascuolar myopathy.
    Itabashi HH; Kökmen E
    Arch Pathol; 1972 Mar; 93(3):209-18. PubMed ID: 5009996
    [No Abstract]   [Full Text] [Related]  

  • 24. Morphologic study of a neuromyopathy caused by prolonged chloroquine treatment.
    Gérard JM; Stoupel N; Collier A; Flament-Durand J
    Eur Neurol; 1973; 9(6):363-79. PubMed ID: 4712543
    [No Abstract]   [Full Text] [Related]  

  • 25. Images in cardiology. Chloroquine-induced transition from dilated to restrictive cardiomyopathy.
    Pieroni M; Smaldone C; Camporeale A; Ierardi C; Dell'Antonio G; Bellocci F; Crea F
    J Am Coll Cardiol; 2011 Jan; 57(4):515. PubMed ID: 21251591
    [No Abstract]   [Full Text] [Related]  

  • 26. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complete heart block following chronic chloroquine treatment].
    Duvic C; Pats B; Rouvier B
    Rev Med Interne; 2000 May; 21(5):462-3. PubMed ID: 10874768
    [No Abstract]   [Full Text] [Related]  

  • 28. Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement.
    Vereckei A; Fazakas A; Baló T; Fekete B; Molnár MJ; Karádi I
    Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):304-6. PubMed ID: 23409733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloroquine retinopathy in Nigerian patients with heart block.
    Magulike NO; Ihenacho HN; Ike VO
    Eye (Lond); 1993; 7 ( Pt 4)():591-3. PubMed ID: 8253245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine myopathy and myasthenia-like syndrome.
    Sghirlanzoni A; Mantegazza R; Mora M; Pareyson D; Cornelio F
    Muscle Nerve; 1988 Feb; 11(2):114-9. PubMed ID: 3343986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine cardiomyopathy: beyond ocular adverse effects.
    Lopez-Ruiz N; Uribe CE
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25225192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
    Wozniacka A; Cygankiewicz I; Chudzik M; Sysa-Jedrzejowska A; Wranicz JK
    Lupus; 2006; 15(8):521-5. PubMed ID: 16942005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What is your diagnosis? Chloroquine-induced neuromyopathy].
    Kappos L; Lehmann R
    Schweiz Rundsch Med Prax; 1991 May; 80(20):543-4. PubMed ID: 2047636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Peripheral nerve lesions in chloroquine-induced neuromyopathies].
    Pagès M; Pagès AM
    Ann Pathol; 1984; 4(4):289-95. PubMed ID: 6095877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pigmentation and retinopathy due to chloroquine.
    Stewart TW; Miles DW; Earnshaw ER
    Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103
    [No Abstract]   [Full Text] [Related]  

  • 36. Chloroquine cardiomyopathy - a review of the literature.
    Tönnesmann E; Kandolf R; Lewalter T
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):434-42. PubMed ID: 23635029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complete atrioventricular block following long term treatment with chloroquine].
    Puymirat E; Douard H; Roudaut R
    Rev Med Interne; 2008 Sep; 29(9):741-3. PubMed ID: 18692276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine-induced cardiomyopathy: a reversible cause of heart failure.
    Yogasundaram H; Hung W; Paterson ID; Sergi C; Oudit GY
    ESC Heart Fail; 2018 Jun; 5(3):372-375. PubMed ID: 29460476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports].
    Becerra-Cuñat JL; Coll-Cantí J; Gelpí-Mantius E; Ferrer-Avellí X; Lozano-Sánchez M; Millán-Torné M; Ojanguren I; Ariza A; Olivé A
    Rev Neurol; 2003 Mar 16-31; 36(6):523-6. PubMed ID: 12652413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
    Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
    N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.